Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP
27 sept. 2023 03h24 HE
|
Chr. Hansen Holding A/S
September 27, 2023 – Company announcement no. 8 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press...
Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion
04 sept. 2023 05h48 HE
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
Chr. Hansen Holding A/S Interim Report Q3 2022/23
06 juil. 2023 02h03 HE
|
Chr. Hansen Holding A/S
July 6, 2023 – Company announcement no. 7 Strong execution by the organization drives solid Q3 results Statement by CEO Mauricio Graber: “The solid results for Q3 prove the strength of the Chr....
Chr. Hansen Holding A/S Interim Report Q2 2022/23
13 avr. 2023 02h02 HE
|
Chr. Hansen Holding A/S
April 13, 2023 – Company announcement no. 6 A strong first half supporting the full-year outlook Statement by CEO Mauricio Graber: “The strong results for Q2 confirm the attractiveness of the...
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
30 mars 2023 12h07 HE
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S
30 mars 2023 11h58 HE
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. ...
Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders
30 mars 2023 07h11 HE
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. MARCH 30,...
Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion
28 mars 2023 06h07 HE
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
Notice to convene Extraordinary General Meeting
08 mars 2023 02h05 HE
|
Chr. Hansen Holding A/S
MARCH 8, 2023 – ANNOUNCEMENT NO. 4 An Extraordinary General Meeting of Chr. Hansen Holding A/S will be held on Thursday, March 30, 2023, at 5:00 p.m. CEST at The Hangar – Clarion...
Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company
08 mars 2023 02h00 HE
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...